These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 6693168)
21. Clostridium botulinum type E toxin: effect of pH and method of purification on molecular weight. Sacks HS; Covert SV Appl Microbiol; 1974 Sep; 28(3):374-82. PubMed ID: 4609265 [TBL] [Abstract][Full Text] [Related]
22. The susceptibility of the mallard duck (Anas platyrhynchos) to Clostridium botulinum C2 toxin. Jensen WI; Duncan RM Jpn J Med Sci Biol; 1980 Apr; 33(2):81-6. PubMed ID: 7412022 [TBL] [Abstract][Full Text] [Related]
23. Molecular composition of Clostridium botulinum type A progenitor toxins. Inoue K; Fujinaga Y; Watanabe T; Ohyama T; Takeshi K; Moriishi K; Nakajima H; Inoue K; Oguma K Infect Immun; 1996 May; 64(5):1589-94. PubMed ID: 8613365 [TBL] [Abstract][Full Text] [Related]
24. Association between the cell-wall peptidoglycan and the progenitor toxin of Clostridium botulinum type C. Hyun SH; Sakaguchi G Nihon Juigaku Zasshi; 1989 Feb; 51(1):169-76. PubMed ID: 2648051 [TBL] [Abstract][Full Text] [Related]
25. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC). Matsuda M; Ozutsumi K; Du PY; Sugimoto N Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554 [TBL] [Abstract][Full Text] [Related]
26. Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan. Kozaki S; Kamata Y; Nishiki T; Kakinuma H; Maruyama H; Takahashi H; Karasawa T; Yamakawa K; Nakamura S Infect Immun; 1998 Oct; 66(10):4811-6. PubMed ID: 9746583 [TBL] [Abstract][Full Text] [Related]
27. Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism. Barash JR; Arnon SS J Clin Microbiol; 2004 Apr; 42(4):1713-5. PubMed ID: 15071029 [TBL] [Abstract][Full Text] [Related]
28. [Extraction and concentration of Clostridium botulinum toxins from specimens (author's transl)]. Sonnenschein B; Bisping W Zentralbl Bakteriol Orig A; 1976 Mar; 234(2):247-59. PubMed ID: 5836 [TBL] [Abstract][Full Text] [Related]
29. Mucosal immunisation with Clostridium botulinum type C 16 S toxoid and its non-toxic component. Mahmut N; Inoue K; Fujinaga Y; Arimitsu H; Sakaguchi Y; Hughes L; Hirst R; Murphy T; Tsuji T; Watanabe T; Ohyama T; Karasawa T; Nakamura S; Yokota K; Oguma K J Med Microbiol; 2002 Oct; 51(10):813-820. PubMed ID: 12435059 [TBL] [Abstract][Full Text] [Related]
30. Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F. Ohishi I; Sakaguchi G Jpn J Med Sci Biol; 1977 Aug; 30(4):179-90. PubMed ID: 20527 [TBL] [Abstract][Full Text] [Related]
31. Activation of a toxic component of Clostridium botulinum types C and D by trypsin. Eklund MW; Poysky FT Appl Microbiol; 1972 Jul; 24(1):108-13. PubMed ID: 4560464 [TBL] [Abstract][Full Text] [Related]
32. Role of a protease in natural activation of Clostridium botulinum neurotoxin. Das Gupta BR; Sugiyama H Infect Immun; 1972 Oct; 6(4):587-90. PubMed ID: 4564288 [TBL] [Abstract][Full Text] [Related]
33. Noncorrelation between mouse toxicity and serologically assayed toxin in Clostridium botulinum type A culture fluids. Betley MJ; Sugiyama H Appl Environ Microbiol; 1979 Aug; 38(2):297-300. PubMed ID: 391153 [TBL] [Abstract][Full Text] [Related]
34. Molecular and Epidemiological Characterization of Infant Botulism in Beijing, China. Dong YP; Wang W; Jiang T; Xu J; Han CH; Yan SF; Fanning S; Li Y; Ma XC; Zhang D; Zhao Y; Zeng B; Li FQ Biomed Environ Sci; 2017 Jun; 30(6):460-464. PubMed ID: 28705271 [TBL] [Abstract][Full Text] [Related]
35. Detection of neutral sugars in purified type G botulinum progenitor toxin and the effects of some glycolytic enzymes on its molecular dissociation and oral toxicity. Nukina M; Miyata T; Sakaguchi S; Sakaguchi G FEMS Microbiol Lett; 1991 Apr; 63(2-3):159-64. PubMed ID: 1905654 [TBL] [Abstract][Full Text] [Related]
36. Distinction between Clostridium botulinum type A strains associated with food-borne botulism and those with infant botulism in Japan in intraintestinal toxin production in infant mice and some other properties. Tabita K; Sakaguchi S; Kozaki S; Sakaguchi G FEMS Microbiol Lett; 1991 Apr; 63(2-3):251-6. PubMed ID: 1905658 [TBL] [Abstract][Full Text] [Related]
37. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type E toxin. Notermans S; Dufrenne J; Kozaki S Appl Environ Microbiol; 1979 Jun; 37(6):1173-5. PubMed ID: 384908 [TBL] [Abstract][Full Text] [Related]
38. Characterization of neurotoxigenic Clostridium butyricum strain by DNA hybridization test and by in vivo and in vitro germination tests of spores. Takeshi K; Fujii N; Kimura K; Yamakawa K; Nakamura S; Kumagai M; Oguma K Microbiol Immunol; 1991; 35(12):1095-103. PubMed ID: 1808463 [TBL] [Abstract][Full Text] [Related]
39. Purification and characterization of two components of botulinum C2 toxin. Ohishi I; Iwasaki M; Sakaguchi G Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232 [TBL] [Abstract][Full Text] [Related]
40. Experimental botulism in chickens: the cecum as the site of production and absorption of botulinum toxin. Miyazaki S; Sakaguchi G Jpn J Med Sci Biol; 1978 Feb; 31(1):1-15. PubMed ID: 351242 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]